1.3.1.48	13,14-dihydro-15-prostaglandin E2	competitive product inhibition	42975	
1.3.1.48	15-keto prostaglandin F2alpha	43.06% residual activity at 0.1 mM	68883	
1.3.1.48	5-(2-chloro-3-((4-methylcyclohexyl)methoxy)benzylidene)-1,3-thiazolidine-2,4-dione	-	224555	
1.3.1.48	5-(2-chloro-3-((5-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)oxy)benzylidene)-1,3-thiazolidine-2,4-dione	-	224566	
1.3.1.48	5-(2-chloro-3-(1-cyclopropylethoxy)benzylidene)-1,3- thiazolidine-2,4-dione	-	224563	
1.3.1.48	5-(2-chloro-3-(2-(4-methyl-1,3-thiazolidin-5-yl)ethoxy)benzylidene)-1,3-thiazolidine-2,4-dione	-	224557	
1.3.1.48	5-(2-chloro-3-(2-(cyclohexyloxy)ethoxy)benzylidene)-1,3-thiazolidine-2,4-dione	-	224560	
1.3.1.48	5-(2-chloro-3-(2-(propan-2-yloxy)ethoxy)benzylidene)-1,3-thiazolidine-2,4-dione	-	224556	
1.3.1.48	5-(2-chloro-3-(2-(pyridin-2-yl)ethoxy)benzylidene)-1,3-thiazolidine-2,4-dione	-	217193	
1.3.1.48	5-(2-chloro-3-(2-cyclohexylethoxy)benzylidene)thiazolidine-2,4-dione	-	224574